QPS Holdings, LLC has completed its acquisition of Xendo Drug Development BV (XDD). XDD, a European CRO headquartered in Groningen, The Netherlands, will be known as QPS Netherlands BV and is a wholly-owned subsidiary of QPS Holdings. XDD has large and small molecule bioanalytical labs and a 24-bed clinical pharmacology unit (CPU) located at University Medical Center Groningen (UMCG). The CPU performs clinical pharmacology studies across all major therapeutic areas and provides comprehensive ...